#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	11074	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2074	526.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1437	1437	C	652	C	632	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3394	610.9	0	.	n	.	0	T695C	SNP	695	695	T	944	944	C	655	C,T	625,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3394	610.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2220	2220	C	684	C,T,A,G	655,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3394	610.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2294	2294	A	633	A	611	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21004	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3394	610.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2846	2846	C	646	C	623	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1408	folP	855	855	100.0	folP.l6.c17.ctg.1	1416	98.3	1	SNP	p	R229S	1	.	.	685	687	AGC	945	947	AGC	135;137;138	A,C;G;C	131,2;136;136	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	112.7	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	138;137;137	T;T;C	136;134;135	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	112.7	1	SNP	p	G95N	0	.	.	283	285	GGC	655	657	GGC	138;136;139	G;G;C	134;133;132	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3988	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3514	112.7	1	SNP	p	D95G	1	.	.	283	285	GGC	655	657	GGC	138;136;139	G;G;C	134;133;132	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1152	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1308	87.4	1	SNP	p	G45D	0	.	.	133	135	GGC	456	458	GGC	149;150;151	G;G;C	144;145;145	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	662	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	888	73.7	0	.	n	.	0	A197.	DEL	197	197	A	593	593	A	174	A	166	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	126.2	1	SNP	p	D86N	0	.	.	256	258	GAC	579	581	GAC	142;142;143	G;A;C	141;138;142	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	126.2	1	SNP	p	R87I	0	.	.	259	261	CGT	582	584	CGT	143;145;145	C,A;G;T	138,5;144;140	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	126.2	1	SNP	p	R87W	0	.	.	259	261	CGT	582	584	CGT	143;145;145	C,A;G;T	138,5;144;140	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	126.2	1	SNP	p	S87R	1	.	.	259	261	CGT	582	584	CGT	143;145;145	C,A;G;T	138,5;144;140	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3768	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2955	126.2	1	SNP	p	S88P	0	.	.	262	264	TCC	585	587	TCC	145;145;147	T;C;C,A	142;145;143,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2908	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2665	108.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1627	1629	GGC	148;148;148	G;G;C	141;144;142	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1269	1271	GCC	185;188;188	G,T;C;C,A	176,1;180;179,1	penA.35.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1272	1274	ATG	189;189;188	A;T;G,C	184;181;183,1	penA.35.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1284	1286	ACC	178;179;177	A,G;C,T;C,G	167,1;173,1;171,1	penA.35.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1284	1286	ACC	178;179;177	A,G;C,T;C,G	167,1;173,1;171,1	penA.35.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1785	1787	ACC	112;112;113	A,G;C,T;C	100,1;103,1;106	penA.35.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1839	1841	GCG	108;107;109	G;C;G	99;89;101	penA.35.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1839	1841	GCG	108;107;109	G;C;G	99;89;101	penA.35.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1962	1964	GGT	105;105;105	G,A;G;T,C	97,3;99;92,4	penA.35.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1971	1973	GGC	103;102;101	G,A,C;G;C	93,5,1;99;98	penA.35.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.35.001	penA.35.001	1	1	27	2776	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2308	118.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1989	1991	CCG	90;91;92	C,G;C,G;G,C	79,2;83,1;81,1	penA.35.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4224	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3239	129.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1681	1683	CCG	148;150;151	C;C;G	141;143;140	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1816	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1728	103.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	126	C	116	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	228	porB1a	984	292	90.88	porB1a.l15.c17.ctg.1	499	18.6	0	.	p	.	0	H217N	NONSYN	649	651	CAT	232	234	AAT	21;21;21	A;A;T	20;21;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	228	porB1a	984	292	90.88	porB1a.l15.c17.ctg.1	499	18.6	0	.	p	.	0	D218N	NONSYN	652	654	GAT	235	237	AAT	21;21;21	A;A;T	21;21;21	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	228	porB1a	984	292	90.88	porB1a.l15.c17.ctg.1	499	18.6	0	.	p	.	0	V226A	NONSYN	676	678	GTA	259	261	GCA	21;20;19	G;C;A	20;20;19	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	228	porB1a	984	292	90.88	porB1a.l15.c17.ctg.1	499	18.6	0	.	p	.	0	.	MULTIPLE	700	702	ACT	282	284	GTA	16;16;15	G;T;A	16;16;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	228	porB1a	984	292	90.88	porB1a.l15.c17.ctg.1	499	18.6	0	.	p	.	0	N237fs	FSHIFT	709	709	A	291	291	A	14	A	14	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	0	.	p	.	0	E38K	NONSYN	112	114	GAA	461	463	AAA	142;143;145	A,G;A;A	126,8;135;135	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	0	.	p	.	0	I45V	NONSYN	133	135	ATT	482	484	GTT	154;154;152	G,A,C;T,G;T	141,5,4;148,1;146	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	0	.	p	.	0	G48E	NONSYN	142	144	GGA	491	493	GAA	163;166;169	G;A,G;A	158;154,5;162	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	1	SNP	p	G120K	1	.	.	358	360	AAG	707	709	AAG	183;184;181	A,G;A,G;G,T	174,1;182,1;174,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	1	SNP	p	A121N	1	.	.	361	363	AAC	710	712	AAC	179;180;183	A,G;A,C;C	175,1;176,1;179	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2162	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1635	131.2	1	SNP	p	N121D	0	.	.	361	363	AAC	710	712	AAC	179;180;183	A,G;A,C;C	175,1;176,1;179	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	7504	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4696	158.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	846	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1191	70.7	1	SNP	p	V57M	1	.	.	169	171	ATG	597	599	ATG	147;149;150	A;T;G,T	141;142;144,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	426	99.53	tetM.l15.c4.ctg.1	661	4.6	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	172	174	ACC	9;9;9	A;C;C	8;8;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	426	99.53	tetM.l15.c4.ctg.1	661	4.6	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	268	270	GAA	4;4;4	G;A;A	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	T190M	NONSYN	568	570	ACG	18	20	ATG	1;1;1	A;T;G	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	L194S	NONSYN	580	582	TTA	30	32	TCA	1;1;1	T;C;A	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	75	77	CAG	3;3;3	C;A;G	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	V216L	NONSYN	646	648	GTT	96	98	CTT	4;4;4	C;T;T	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	N223S	NONSYN	667	669	AAC	117	119	AGT	4;4;4	A;G;T	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	186	188	CCG	9;9;9	C;C;G	8;8;8	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	P280S	NONSYN	838	840	CCG	288	290	TCG	5;5;5	T;C;G	5;5;5	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	459	461	AAA	2;2;3	A;A;A	2;2;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	462	464	AAG	2;2;2	A;A;G	2;2;2	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	477	479	CAC	3;3;3	C;A;C	3;3;3	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	516	518	GAA	4;4;4	G;A;A	4;4;4	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	615	93.33	tetM.l15.c4.ctg.2	615	4.2	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	594	596	ACG	1;1;1	A;C;G	1;1;1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	512	100	tetM	1920	514	99.81	tetM.l15.c4.ctg.4	517	6.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	504	506	ACG	1;1;1	A;C;G	1;1;1	.	Tetracycline resistance
